New CATH2 derivatives

The present invention provides new derivatives of CATH2 or CMAP27, one of the cathelicidins. These derivatives comprise N-terminally truncated peptides, cyclic peptides, D-amino acid variants of CATH2 and its truncated derivatives, inverso and retro-inverso CATH2 derivatives. These derivatives are u...

Full description

Saved in:
Bibliographic Details
Main Authors Haagsman, Hendrik Peter, Van Dijk, Albert, Veldhuizen, Edwin Johannes Adrianus
Format Patent
LanguageEnglish
Published 19.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention provides new derivatives of CATH2 or CMAP27, one of the cathelicidins. These derivatives comprise N-terminally truncated peptides, cyclic peptides, D-amino acid variants of CATH2 and its truncated derivatives, inverso and retro-inverso CATH2 derivatives. These derivatives are useful as anti-infectives, in vaccines, and especially for in ovo applications. Further, for the above derivatives and also for the already known C-terminally truncated derivatives new immunoactivating functions have been described that are particularly advantageous for prophylactic treatments.
Bibliography:Application Number: AU20150256729